Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jana Zecha

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Cell Reports|July 30, 2020
PTPN2 Deficiency Enhances Programmed T Cell Expansion and Survival Capacity of Activated T CellsMarkus Flosbach, Susanne G Oberle, Stefanie Scherer, et al.
Nucleic Acids Research|October 31, 2019
ProteomicsDB: a multi-omics and multi-organism resource for life science researchPatroklos Samaras, Tobias Schmidt, Martin Frejno, et al.
The EMBO Journal|September 5, 2022
The OTUD6B-LIN28B-MYC axis determines the proliferative state in multiple myelomaCarmen Paulmann, Ria Spallek, Oleksandra Karpiuk, et al.
Nature Communications|January 11, 2020
Robust, reproducible and quantitative analysis of thousands of proteomes by micro-flow LC-MS/MSYangyang Bian, Runsheng Zheng, Florian P Bayer, et al.
Nature Communications|July 21, 2020
Proteome activity landscapes of tumor cell lines determine drug responsesMartin Frejno, Chen Meng, Benjamin Ruprecht, et al.
Molecular Systems Biology|February 20, 2019
A deep proteome and transcriptome abundance atlas of 29 healthy human tissuesDongxue Wang, Basak Eraslan, Thomas Wieland, et al.
Molecular Cell|February 11, 2021
The IMiD target CRBN determines HSP90 activity toward transmembrane proteins essential in multiple myelomaMichael Heider, Ruth Eichner, Jacob Stroh, et al.
Nature Methods|April 15, 2020
Meltome atlas-thermal proteome stability across the tree of lifeAnna Jarzab, Nils Kurzawa, Thomas Hopf, et al.
Cell Reports. Medicine|March 5, 2023
A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA and adenovirus vectored vaccinesFeargal J Ryan, Todd S Norton, Conor McCafferty, et al.
Science (New York, N.Y.)|March 17, 2023
Decrypting drug actions and protein modifications by dose- and time-resolved proteomicsJana Zecha, Florian P Bayer, Svenja Wiechmann, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Cell Reports|July 30, 2020
PTPN2 Deficiency Enhances Programmed T Cell Expansion and Survival Capacity of Activated T CellsMarkus Flosbach, Susanne G Oberle, Stefanie Scherer, et al.
Nucleic Acids Research|October 31, 2019
ProteomicsDB: a multi-omics and multi-organism resource for life science researchPatroklos Samaras, Tobias Schmidt, Martin Frejno, et al.
The EMBO Journal|September 5, 2022
The OTUD6B-LIN28B-MYC axis determines the proliferative state in multiple myelomaCarmen Paulmann, Ria Spallek, Oleksandra Karpiuk, et al.
Nature Communications|January 11, 2020
Robust, reproducible and quantitative analysis of thousands of proteomes by micro-flow LC-MS/MSYangyang Bian, Runsheng Zheng, Florian P Bayer, et al.
Nature Communications|July 21, 2020
Proteome activity landscapes of tumor cell lines determine drug responsesMartin Frejno, Chen Meng, Benjamin Ruprecht, et al.
Molecular Systems Biology|February 20, 2019
A deep proteome and transcriptome abundance atlas of 29 healthy human tissuesDongxue Wang, Basak Eraslan, Thomas Wieland, et al.
Molecular Cell|February 11, 2021
The IMiD target CRBN determines HSP90 activity toward transmembrane proteins essential in multiple myelomaMichael Heider, Ruth Eichner, Jacob Stroh, et al.
Nature Methods|April 15, 2020
Meltome atlas-thermal proteome stability across the tree of lifeAnna Jarzab, Nils Kurzawa, Thomas Hopf, et al.
Cell Reports. Medicine|March 5, 2023
A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA and adenovirus vectored vaccinesFeargal J Ryan, Todd S Norton, Conor McCafferty, et al.
Science (New York, N.Y.)|March 17, 2023
Decrypting drug actions and protein modifications by dose- and time-resolved proteomicsJana Zecha, Florian P Bayer, Svenja Wiechmann, et al.
Pageof 3